ADRB2 signaling promotes HCC progression and sorafenib resistance by inhibiting autophagic degradation of HIF1α

Graphical abstract

Saved in:
Bibliographic Details
Published in:Journal of hepatology 2016-08, Vol.65 (2), p.314-324
Main Authors: Wu, Fu-Quan, Fang, Tian, Yu, Le-Xing, Lv, Gui-Shuai, Lv, Hong-Wei, Liang, Dong, Li, Ting, Wang, Chang-Zheng, Tan, Ye-Xiong, Ding, Jin, Chen, Yao, Tang, Liang, Guo, Lin-Na, Tang, Shan-Hua, Yang, Wen, Wang, Hong-Yang
Format: Article
Language:English
Subjects:
Animals
Autophagy
Beta-2 adrenergic receptor
Carcinoma, Hepatocellular
Disease Progression
Drug Resistance, Neoplasm
Gastroenterology and Hepatology
Humans
Liver cancer
Liver Neoplasms
Mice
Mice, Nude
Niacinamide - analogs & derivatives
Phenylurea Compounds
Receptors, Adrenergic, beta-2
Signal Transduction
Sorafenib resistance
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c411t-3d73b4e11f0e6cb16677d34870149c35292c7814caeea9a53a5df3f04f7a39ad3
cites cdi_FETCH-LOGICAL-c411t-3d73b4e11f0e6cb16677d34870149c35292c7814caeea9a53a5df3f04f7a39ad3
container_end_page 324
container_issue 2
container_start_page 314
container_title Journal of hepatology
container_volume 65
creator Wu, Fu-Quan
Fang, Tian
Yu, Le-Xing
Lv, Gui-Shuai
Lv, Hong-Wei
Liang, Dong
Li, Ting
Wang, Chang-Zheng
Tan, Ye-Xiong
Ding, Jin
Chen, Yao
Tang, Liang
Guo, Lin-Na
Tang, Shan-Hua
Yang, Wen
Wang, Hong-Yang
description Graphical abstract
doi_str_mv 10.1016/j.jhep.2016.04.019
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1805760905</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0168827816301635</els_id><sourcerecordid>1805760905</sourcerecordid><originalsourceid>FETCH-LOGICAL-c411t-3d73b4e11f0e6cb16677d34870149c35292c7814caeea9a53a5df3f04f7a39ad3</originalsourceid><addsrcrecordid>eNp9kc1u1DAUhS1ERaeFF2CBvGSTcB07fxJCKgNlKlVC4mdtOfZNxiETBztBmsfqi_BMdTSliy5Y-do-50j3O4S8ZpAyYMW7Pu33OKVZnFMQKbD6GdmwAiCBQrDnZBM_qqTKyuqcXITQAwCHWrwg51nJcgEF25Dp6tO3jxkNthvVYMeOTt4d3IyB7rbb9dJ5DMG6karR0OC8anG0DY2vNsxq1EibI7Xj3jZ2Xv1qmd20V53V1GDnlVHz6nYt3d1cs793L8lZq4aArx7OS_Lz-vOP7S65_frlZnt1m2jB2JxwU_JGIGMtYKEbVhRlabioSmCi1jzP6kyXFRNaIapa5VzlpuUtiLZUvFaGX5K3p9y4w-8FwywPNmgcBjWiW4JkFeRlATXkUZqdpNq7EDy2cvL2oPxRMpAradnLlbRcSUsQMpKOpjcP-UtzQPNo-Yc2Ct6fBBi3_GPRy6AtRmDGetSzNM7-P__DE7uO_Vithl94xNC7xcfG4h4yZBLk97XrtWpW8DjynN8D1mSlMg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1805760905</pqid></control><display><type>article</type><title>ADRB2 signaling promotes HCC progression and sorafenib resistance by inhibiting autophagic degradation of HIF1α</title><source>ScienceDirect Journals</source><creator>Wu, Fu-Quan ; Fang, Tian ; Yu, Le-Xing ; Lv, Gui-Shuai ; Lv, Hong-Wei ; Liang, Dong ; Li, Ting ; Wang, Chang-Zheng ; Tan, Ye-Xiong ; Ding, Jin ; Chen, Yao ; Tang, Liang ; Guo, Lin-Na ; Tang, Shan-Hua ; Yang, Wen ; Wang, Hong-Yang</creator><creatorcontrib>Wu, Fu-Quan ; Fang, Tian ; Yu, Le-Xing ; Lv, Gui-Shuai ; Lv, Hong-Wei ; Liang, Dong ; Li, Ting ; Wang, Chang-Zheng ; Tan, Ye-Xiong ; Ding, Jin ; Chen, Yao ; Tang, Liang ; Guo, Lin-Na ; Tang, Shan-Hua ; Yang, Wen ; Wang, Hong-Yang</creatorcontrib><description>Graphical abstract</description><identifier>ISSN: 0168-8278</identifier><identifier>EISSN: 1600-0641</identifier><identifier>DOI: 10.1016/j.jhep.2016.04.019</identifier><identifier>PMID: 27154061</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Animals ; Autophagy ; Beta-2 adrenergic receptor ; Carcinoma, Hepatocellular ; Disease Progression ; Drug Resistance, Neoplasm ; Gastroenterology and Hepatology ; Humans ; Liver cancer ; Liver Neoplasms ; Mice ; Mice, Nude ; Niacinamide - analogs &amp; derivatives ; Phenylurea Compounds ; Receptors, Adrenergic, beta-2 ; Signal Transduction ; Sorafenib resistance</subject><ispartof>Journal of hepatology, 2016-08, Vol.65 (2), p.314-324</ispartof><rights>European Association for the Study of the Liver</rights><rights>2016 European Association for the Study of the Liver</rights><rights>Copyright © 2016 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c411t-3d73b4e11f0e6cb16677d34870149c35292c7814caeea9a53a5df3f04f7a39ad3</citedby><cites>FETCH-LOGICAL-c411t-3d73b4e11f0e6cb16677d34870149c35292c7814caeea9a53a5df3f04f7a39ad3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27154061$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wu, Fu-Quan</creatorcontrib><creatorcontrib>Fang, Tian</creatorcontrib><creatorcontrib>Yu, Le-Xing</creatorcontrib><creatorcontrib>Lv, Gui-Shuai</creatorcontrib><creatorcontrib>Lv, Hong-Wei</creatorcontrib><creatorcontrib>Liang, Dong</creatorcontrib><creatorcontrib>Li, Ting</creatorcontrib><creatorcontrib>Wang, Chang-Zheng</creatorcontrib><creatorcontrib>Tan, Ye-Xiong</creatorcontrib><creatorcontrib>Ding, Jin</creatorcontrib><creatorcontrib>Chen, Yao</creatorcontrib><creatorcontrib>Tang, Liang</creatorcontrib><creatorcontrib>Guo, Lin-Na</creatorcontrib><creatorcontrib>Tang, Shan-Hua</creatorcontrib><creatorcontrib>Yang, Wen</creatorcontrib><creatorcontrib>Wang, Hong-Yang</creatorcontrib><title>ADRB2 signaling promotes HCC progression and sorafenib resistance by inhibiting autophagic degradation of HIF1α</title><title>Journal of hepatology</title><addtitle>J Hepatol</addtitle><description>Graphical abstract</description><subject>Animals</subject><subject>Autophagy</subject><subject>Beta-2 adrenergic receptor</subject><subject>Carcinoma, Hepatocellular</subject><subject>Disease Progression</subject><subject>Drug Resistance, Neoplasm</subject><subject>Gastroenterology and Hepatology</subject><subject>Humans</subject><subject>Liver cancer</subject><subject>Liver Neoplasms</subject><subject>Mice</subject><subject>Mice, Nude</subject><subject>Niacinamide - analogs &amp; derivatives</subject><subject>Phenylurea Compounds</subject><subject>Receptors, Adrenergic, beta-2</subject><subject>Signal Transduction</subject><subject>Sorafenib resistance</subject><issn>0168-8278</issn><issn>1600-0641</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><recordid>eNp9kc1u1DAUhS1ERaeFF2CBvGSTcB07fxJCKgNlKlVC4mdtOfZNxiETBztBmsfqi_BMdTSliy5Y-do-50j3O4S8ZpAyYMW7Pu33OKVZnFMQKbD6GdmwAiCBQrDnZBM_qqTKyuqcXITQAwCHWrwg51nJcgEF25Dp6tO3jxkNthvVYMeOTt4d3IyB7rbb9dJ5DMG6karR0OC8anG0DY2vNsxq1EibI7Xj3jZ2Xv1qmd20V53V1GDnlVHz6nYt3d1cs793L8lZq4aArx7OS_Lz-vOP7S65_frlZnt1m2jB2JxwU_JGIGMtYKEbVhRlabioSmCi1jzP6kyXFRNaIapa5VzlpuUtiLZUvFaGX5K3p9y4w-8FwywPNmgcBjWiW4JkFeRlATXkUZqdpNq7EDy2cvL2oPxRMpAradnLlbRcSUsQMpKOpjcP-UtzQPNo-Yc2Ct6fBBi3_GPRy6AtRmDGetSzNM7-P__DE7uO_Vithl94xNC7xcfG4h4yZBLk97XrtWpW8DjynN8D1mSlMg</recordid><startdate>20160801</startdate><enddate>20160801</enddate><creator>Wu, Fu-Quan</creator><creator>Fang, Tian</creator><creator>Yu, Le-Xing</creator><creator>Lv, Gui-Shuai</creator><creator>Lv, Hong-Wei</creator><creator>Liang, Dong</creator><creator>Li, Ting</creator><creator>Wang, Chang-Zheng</creator><creator>Tan, Ye-Xiong</creator><creator>Ding, Jin</creator><creator>Chen, Yao</creator><creator>Tang, Liang</creator><creator>Guo, Lin-Na</creator><creator>Tang, Shan-Hua</creator><creator>Yang, Wen</creator><creator>Wang, Hong-Yang</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20160801</creationdate><title>ADRB2 signaling promotes HCC progression and sorafenib resistance by inhibiting autophagic degradation of HIF1α</title><author>Wu, Fu-Quan ; Fang, Tian ; Yu, Le-Xing ; Lv, Gui-Shuai ; Lv, Hong-Wei ; Liang, Dong ; Li, Ting ; Wang, Chang-Zheng ; Tan, Ye-Xiong ; Ding, Jin ; Chen, Yao ; Tang, Liang ; Guo, Lin-Na ; Tang, Shan-Hua ; Yang, Wen ; Wang, Hong-Yang</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c411t-3d73b4e11f0e6cb16677d34870149c35292c7814caeea9a53a5df3f04f7a39ad3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Animals</topic><topic>Autophagy</topic><topic>Beta-2 adrenergic receptor</topic><topic>Carcinoma, Hepatocellular</topic><topic>Disease Progression</topic><topic>Drug Resistance, Neoplasm</topic><topic>Gastroenterology and Hepatology</topic><topic>Humans</topic><topic>Liver cancer</topic><topic>Liver Neoplasms</topic><topic>Mice</topic><topic>Mice, Nude</topic><topic>Niacinamide - analogs &amp; derivatives</topic><topic>Phenylurea Compounds</topic><topic>Receptors, Adrenergic, beta-2</topic><topic>Signal Transduction</topic><topic>Sorafenib resistance</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wu, Fu-Quan</creatorcontrib><creatorcontrib>Fang, Tian</creatorcontrib><creatorcontrib>Yu, Le-Xing</creatorcontrib><creatorcontrib>Lv, Gui-Shuai</creatorcontrib><creatorcontrib>Lv, Hong-Wei</creatorcontrib><creatorcontrib>Liang, Dong</creatorcontrib><creatorcontrib>Li, Ting</creatorcontrib><creatorcontrib>Wang, Chang-Zheng</creatorcontrib><creatorcontrib>Tan, Ye-Xiong</creatorcontrib><creatorcontrib>Ding, Jin</creatorcontrib><creatorcontrib>Chen, Yao</creatorcontrib><creatorcontrib>Tang, Liang</creatorcontrib><creatorcontrib>Guo, Lin-Na</creatorcontrib><creatorcontrib>Tang, Shan-Hua</creatorcontrib><creatorcontrib>Yang, Wen</creatorcontrib><creatorcontrib>Wang, Hong-Yang</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of hepatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wu, Fu-Quan</au><au>Fang, Tian</au><au>Yu, Le-Xing</au><au>Lv, Gui-Shuai</au><au>Lv, Hong-Wei</au><au>Liang, Dong</au><au>Li, Ting</au><au>Wang, Chang-Zheng</au><au>Tan, Ye-Xiong</au><au>Ding, Jin</au><au>Chen, Yao</au><au>Tang, Liang</au><au>Guo, Lin-Na</au><au>Tang, Shan-Hua</au><au>Yang, Wen</au><au>Wang, Hong-Yang</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>ADRB2 signaling promotes HCC progression and sorafenib resistance by inhibiting autophagic degradation of HIF1α</atitle><jtitle>Journal of hepatology</jtitle><addtitle>J Hepatol</addtitle><date>2016-08-01</date><risdate>2016</risdate><volume>65</volume><issue>2</issue><spage>314</spage><epage>324</epage><pages>314-324</pages><issn>0168-8278</issn><eissn>1600-0641</eissn><abstract>Graphical abstract</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>27154061</pmid><doi>10.1016/j.jhep.2016.04.019</doi><tpages>11</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0168-8278
ispartof Journal of hepatology, 2016-08, Vol.65 (2), p.314-324
issn 0168-8278
1600-0641
language eng
recordid cdi_proquest_miscellaneous_1805760905
source ScienceDirect Journals
subjects Animals
Autophagy
Beta-2 adrenergic receptor
Carcinoma, Hepatocellular
Disease Progression
Drug Resistance, Neoplasm
Gastroenterology and Hepatology
Humans
Liver cancer
Liver Neoplasms
Mice
Mice, Nude
Niacinamide - analogs & derivatives
Phenylurea Compounds
Receptors, Adrenergic, beta-2
Signal Transduction
Sorafenib resistance
title ADRB2 signaling promotes HCC progression and sorafenib resistance by inhibiting autophagic degradation of HIF1α
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T22%3A00%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=ADRB2%20signaling%20promotes%20HCC%20progression%20and%20sorafenib%20resistance%20by%20inhibiting%20autophagic%20degradation%20of%20HIF1%CE%B1&rft.jtitle=Journal%20of%20hepatology&rft.au=Wu,%20Fu-Quan&rft.date=2016-08-01&rft.volume=65&rft.issue=2&rft.spage=314&rft.epage=324&rft.pages=314-324&rft.issn=0168-8278&rft.eissn=1600-0641&rft_id=info:doi/10.1016/j.jhep.2016.04.019&rft_dat=%3Cproquest_cross%3E1805760905%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c411t-3d73b4e11f0e6cb16677d34870149c35292c7814caeea9a53a5df3f04f7a39ad3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1805760905&rft_id=info:pmid/27154061&rfr_iscdi=true